A new study published in the journal of Therapeutic Advances in Respiratory Disease showed that after just 4 to 8 weeks, ...

The first comprehensive analysis of three lung diseases across the England, Wales, Scotland, and Northern Ireland has been ...

This is part two of a two-part Healio Exclusive series on nutrition and lung health. Part one can be viewed here. Diet is an ...

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

Triple therapy inhalers are expected to account for 11.3% of the total market. The chronic obstructive pulmonary disease ...

Climate change is affecting the health of all individuals and represents an even more significant health risk for individuals with COPD.

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) for chronic ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new ...

For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical ...